Shanghai, China, 15 June 2025 — MicroPort^® MedBot™ recently announced that cumulative global orders for its robotic-assisted surgical system have exceeded 130 units, highlighting the accelerating adoption of its technologies across endoscopic, orthopedic, and vascular specialties. 

At the forefront is the company’s flagship product Toumai^® Surgical Robot, which has secured more than 70 commercial orders, with over 50 units already installed worldwide. To date, Toumai^® has supported more than 10,000 procedures. The system has received regulatory clearance in over 30 countries and regions, reflecting its clinical reliability and global reach.

In January 2025, MicroPort^® MedBot™ further expanded its orthopedic footprint with the SkyWalker^® Orthopedic Surgical Robot, which obtained market approval from Health Canada — a significant step toward deepening its presence in major global markets.

The company also achieved a major milestone in telesurgery innovation. In April, Toumai^® became the world’s first surgical robot to receive regulatory approval for full-spectrum remote surgical applications. Soon after, it enabled Europe’s first robot-assisted telesurgery, conducted by a Belgian surgeon via a hospital-grade V-LAN network with an ultra-low latency of just 20 milliseconds. 

As it continues to expand its global presence, MicroPort® MedBot™ remains dedicated to redefining surgical precision, connectivity, and accessibility through its advanced robotic platforms.

More information is available at: www.medbotsurgical.com/en